Law Office of Brodsky & Smith, LLC Announces Investigation of Cymer, Inc.

  Law Office of Brodsky & Smith, LLC Announces Investigation of Cymer, Inc.

Business Wire

BALA CYNWYD, Pa. -- October 20, 2012

Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Cymer, Inc. (“Cymer” or the
“Company”) (Nasdaq:CYMI) relating to the proposed acquisition by ASML Holding
NV. (“ASML”).

Under the terms of the transaction, Cymer shareholders will receive only a
fixed 1.1502 shares of ASML ordinary stock plus $20.00 in cash for each share
on Cymer common stock they own. The transaction values Cymer at approximately
$81.64. The investigation concerns possible breaches of fiduciary duty and
other violations of state law by the Board of Directors of Cymer for not
acting in the Company’s shareholders' best interests in connection with the
sale process to ASML. Cymer has reported second quarter of 2012 results which
beat analyst estimates by 600%. In addition, this marketed the seventh time in
the previous eight quarters that Cymer’s revenue exceeded analyst
expectations. As a result, the transaction may undervalue the Company and
prevent Cymer shareholders from participating in Cymer’s continued growth.

If you own shares of Cymer stock and wish to discuss the legal ramifications
of the proposed transaction, or have any questions, you may e-mail or call the
law office of Brodsky & Smith, LLC who will, without obligation or cost to
you, attempt to answer your questions. You may contact Jason L. Brodsky,
Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza,
Suite 602, Bala Cynwyd, PA 19004, by e-mail at visiting, by calling toll free


Brodsky & Smith, LLC
Jason L. Brodsky, Esquire
Evan J. Smith, Esquire
Press spacebar to pause and continue. Press esc to stop.